Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
7.14
-0.31 (-4.16%)
At close: Sep 25, 2026, 4:00 PM EDT
7.07
-0.07 (-0.96%)
After-hours: Sep 25, 2026, 7:42 PM EDT
CRBP Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
36
Market Cap
138.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 881.71K | -3.06M | -77.61% |
| Dec 31, 2020 | 3.94M | -32.21M | -89.11% |
| Dec 31, 2019 | 36.14M | 31.32M | 649.51% |
| Dec 31, 2018 | 4.82M | 2.38M | 97.62% |
| Dec 31, 2017 | 2.44M | 528.77K | 27.66% |
| Dec 31, 2016 | 1.91M | 1.26M | 194.80% |
| Dec 31, 2015 | 648.38K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Codexis | 77.68M |
| Atrium Therapeutics | 35.84M |
| Caribou Biosciences | 10.04M |
| Armata Pharmaceuticals | 5.54M |
| Korro Bio | 2.38M |
| Kazia Therapeutics | 1.27M |
| Spruce Biosciences | 697.00K |
CRBP News
- 12 days ago - Corbus Pharmaceuticals Holdings Transcript: Study result - Transcripts
- 12 days ago - Corbus Pharmaceuticals Holdings Press release: Study result - Filings
- 12 days ago - Corbus Pharmaceuticals Holdings Slides: Study result - Filings
- 12 days ago - Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity - GlobeNewsWire
- 15 days ago - Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity - GlobeNewsWire
- 5 weeks ago - Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Corbus Pharmaceuticals Holdings Earnings release: Q2 2026 - Filings
- 7 weeks ago - Corbus Pharmaceuticals Holdings Quarterly report: Q2 2026 - Filings